Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. - Wikidata - wikimedia - TriplyDB

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

http://www.wikidata.org/entity/Q34118035

about

Diuretics for heart failure Diuretics for heart failure Diuretics for heart failure Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates Cardiorenal syndrome: a cardiologist's perspective of pathophysiology Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.A reappraisal of loop diuretic choice in heart failure patients The role of ultrafiltration in patients with decompensated heart failure.Neuroendocrine activity in untreated heart failure Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.Results of clinical trials with diuretics in heart failure.Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.Diuretic use in heart failure and outcomes.Therapeutic options for the management of the cardiorenal syndrome.Association between fluid balance and survival in critically ill patients Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure Drug therapy in chronic heart failure.Aldosterone receptor antagonists: biology and novel therapeutical applications.Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching Recent advances in natriuretic peptides in congestive heart failure.Diuretic usage in heart failure: a continuing conundrum in 2005.Predictors of emergency department observation unit outcomes.Ultrafiltration for acute decompensated heart failure.Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure.Nesiritide: harmful or harmless?Adaptation of renal function in heart failure.Relationship of Loop Diuretic Dosing and Acute Changes in Renal Function during Hospitalization for Heart Failure.Carvedilol: use in chronic heart failure.Approaches to decongestion in patients with acute decompensated heart failure.The place of ACE inhibitors in the current treatment of chronic heart failure.Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Vascular tone in heart failure: the neuroendocrine-therapeutic interface Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis.Acute Kidney Injury in Pediatric Heart Failure Clinical Characteristics and Treatment of Cardiomyopathies in Children.Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

P2860

Q24185944-F7F0A037-101F-4DDA-941B-3A0F20217190 Q24203661-91BF70CE-8FE9-41D2-8C8B-11D25F605D3F Q24244710-F31F48AD-228E-4AB0-91EB-BC91DF16A64A Q24515325-E331787A-FA0A-4BFE-B5A5-2DCDE347DE4D Q27023089-DF52A8FA-12C2-4BDB-BEF6-30A5B64E71C8 Q28257885-C35F8B50-5ECA-43A5-AE46-7446DEEFB08A Q28258044-0926E9D4-C8C0-47E8-A49D-CB0F47B09A9A Q30433871-5BDF62B5-70D0-478C-8145-AD0FC4717840 Q33611263-58365EB2-294F-4649-A948-C8EA3C8D9A1B Q33611337-814F02D3-3B7E-404F-8882-971702BB5016 Q33611888-EC1262F3-F9D4-40A0-B694-747F90FDE267 Q33613458-BFFDD33F-24D9-4F50-AC12-0ECCCC87161F Q33614258-B7F93E04-01FD-4AA3-B9BF-B26BFE9FB1C3 Q33614319-31BCB513-FCCE-462F-8870-B06020EF9ED8 Q33973976-DD646121-1C29-4557-9DB1-75CD459988C9 Q34305164-C4F0DC36-6278-481A-99ED-2A6F09301C20 Q34357452-463FE16A-CA25-46DC-8517-D4D658D9F3DE Q34442587-06C84EB9-6966-459F-8FEA-63121C93D61E Q34696390-0E4BE504-81CF-425F-B91F-673CC39DC08C Q35071595-C7A00928-6502-47C7-B32D-A1B8CAE3DA94 Q35518236-BFE35B96-76BD-4A80-BC76-3F7F8BF3BC7E Q35605655-206D74C1-6709-460C-8B4A-2F7B6ECD0AEB Q35647794-7F2E061C-0A3A-4F98-876D-5F07A4A3CBFB Q35790792-365602ED-4033-4D9E-9A67-9ED909DADB04 Q36056333-8F08BA59-B2EA-4360-B429-29832BBF9865 Q36248577-50EE4C51-AD68-4183-96D0-58283B85F4B7 Q36315167-B02E8A09-8FFA-4C95-B6AC-15C121DCA90F Q36458380-E99F1CF0-D0E8-45A9-BF87-C1D9A359B192 Q36603228-6FEB3B20-B0D9-4734-8701-279CDF9E5AA7 Q36627825-A3BB0678-CBA2-47E5-B915-F1E2970C2C3E Q36670577-62B09556-18B2-43CC-A950-AD7CBA8DDD40 Q36691623-48B5418A-A0CC-48C2-823B-67A2F291C369 Q36694354-7EF4D3D2-B666-4B8A-95DC-E284BEC5A2AF Q36722535-844882E7-CE43-4ADB-A947-DAE750BB8314 Q36743923-379098A1-E609-4404-8E88-602B2C0DEFA7 Q36808117-10F619BA-ECF5-49A7-904A-40E1F3664841 Q36833522-49A038BE-B2F9-4226-92C2-11F1DC8F999E Q36886257-4F06EF12-86BE-49DE-9371-6CE5E2CFB98B Q36886275-52448AB0-DDC0-478A-9687-FBA1C717D424 Q37170615-0384FF5C-FDFB-42C3-9A2D-A5C1B2A836B3

P2860

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

http://www.wikidata.org/entity/Q34118035

description

1987 nî lūn-bûn

@nan

1987 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@ast

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@en

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@nl

type

label

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@ast

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@en

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@nl

prefLabel

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@ast

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@en

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@nl

P1433

Q34118035-73248995-D526-4CC8-9CC4-5ECEDC6E57F4

P1476

Q34118035-50BFF57D-BB8A-4DF0-B9BC-2D523F78D7AB

P2093

Q34118035-1A7141A5-BE44-42FB-954D-895233F7A0CD

Q34118035-33006DCC-B2BC-4883-8873-962C23673526

Q34118035-83C2A88F-8525-4CEB-8ACB-034F39D84774

Q34118035-CDDA29F5-D142-4970-AE59-BC2CA08991A7

Q34118035-FB29BF07-20C8-4DA1-9F26-B1411BDB3A11

P2860

Q34118035-04872816-2144-4262-A1F9-B9CCCBF75484

Q34118035-0F068314-C98A-4B1A-B9C7-FCE667EEC13B

Q34118035-25A02BD7-BC32-4CDC-92A3-9359700104B3

Q34118035-28468273-CB0C-434E-90E5-1E84101E0214

Q34118035-29DCEF96-4A12-4426-846D-D7B8EABAED40

Q34118035-2E46854E-3053-4DF7-B60E-A2B6D6748159

Q34118035-BD4A6DA6-35B9-4E70-A89E-829431FBB07F

Q34118035-D92606E4-B94F-4810-ABDD-4935163D1EC8

Q34118035-E465CFD8-FC7D-469F-8AD6-90312C94D85B

Q34118035-ED71556D-E5BA-4A5D-9F64-6F7752379771

P304

Q34118035-69C1F2D5-D22E-48E8-83F7-2C5C0277AE00

P31

Q34118035-7AC36768-8F31-45DB-951B-7B93EBF904A9

P356

Q34118035-C5F27BCF-EF9B-4C02-9135-5C402E0798BD

P433

Q34118035-30D50802-FC01-4F83-9DB0-3DDC491086B9

P478

Q34118035-7A957AB3-B4B3-4102-83BC-1D0BD5F89342

P577

Q34118035-084D6043-B715-4E48-8A2D-C58DE95941A9

P5875

Q34118035-64DE1A88-7BA2-4F23-AACA-14EC16FA1404

P698

Q34118035-950797DF-0E1A-4DFF-ABA0-46382AA868A4

P921

Q34118035-41E9F33A-4E82-4CB5-8967-0CE87AEAE2DE

P932

Q34118035-3DE40479-BD62-4BEF-90D9-73BD86CBAF21

P356

P1433

British heart journal

P1476

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.

@en

P2093

Bayliss J

http://www.w3.org/2001/XMLSchema#string

Canepa-Anson R

http://www.w3.org/2001/XMLSchema#string

Norell M

http://www.w3.org/2001/XMLSchema#string

Poole-Wilson P

http://www.w3.org/2001/XMLSchema#string

Sutton G

http://www.w3.org/2001/XMLSchema#string

P2860

Symptoms limiting exercise in chronic heart failure

Treatment of chronic heart failure: a review of recent drug trials

Respiratory gas exchange in the assessment of patients with impaired ventricular function.

Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease.

Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures

Neurohumoral control mechanisms in congestive heart failure.

Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.

Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage.

Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function.

A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

P304

17-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.57.1.17

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

1987-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224883641

http://www.w3.org/2001/XMLSchema#string

P698

3541995

http://www.w3.org/2001/XMLSchema#string

P921

P932

1277140

http://www.w3.org/2001/XMLSchema#string